Pathologic, radiologic and PET scan response of gastrointestinal stromal tumors after neoadjuvant treatment with imatinib mesylate

被引:32
|
作者
Goh, B. K. P.
Chow, P. K. H.
Chuah, K. L.
Yap, W. M.
Wong, W. K.
机构
[1] Singapore Gen Hosp, Dept Surg, Singapore 169608, Singapore
[2] Singapore Gen Hosp, Dept Pathol, Singapore 169608, Singapore
来源
EJSO | 2006年 / 32卷 / 09期
关键词
gastrointestinal stromal tumor; GIST; neoadjuvant; imatinib; Gleevec; response;
D O I
10.1016/j.ejso.2006.06.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: The aim of this study is to review the radiologic, PET scan and pathologic response and the outcome of patients with advanced GIST treated with neoadjuvant IM followed by surgical resection. Materials and methods: We report a case and review 36 patients reported in MEDLINE with advanced GIST treated with neoadjuvant IM followed by surgical resection. Results: Thirty-seven patients with a median age of 56 years (range, 32-76 years) at presentation were treated with neoadjuvant IM. Radiologic response accurately predicted pathological response in 31/36 patients, whereas PET scan was accurate in predicting treatment response in only 6/23 patients. Conclusion: This study demonstrates that the pathologic response of GIST to IM is usually incomplete and does not correlate with the complete response seen on PET scan. This finding suggests that surgical resection will continue to play a vital role in the treatment of patients with advanced disease responding to IM treatment. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:961 / 963
页数:3
相关论文
共 50 条
  • [41] CT and PET: Early prognostic indicators of response to imatinib mesylate in patients with gastrointestinal stromal tumor
    Holdsworth, Clay H.
    Badawi, Ramsey D.
    Manola, Judith B.
    Kijewski, Marie F.
    Israel, David A.
    Demetri, George D.
    Van den Abbeele, Annick D.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2007, 189 (06) : W324 - W330
  • [42] The DREAM complex in antitumor activity of imatinib mesylate in gastrointestinal stromal tumors
    DeCaprio, James A.
    Duensing, Anette
    CURRENT OPINION IN ONCOLOGY, 2014, 26 (04) : 415 - 421
  • [43] Update on imatinib for gastrointestinal stromal tumors: duration of treatment
    Linch, Mark
    Claus, Jeroen
    Benson, Charlotte
    ONCOTARGETS AND THERAPY, 2013, 6 : 1011 - 1023
  • [44] Surgical Treatment of Gastrointestinal Stromal Tumors Located in the Stomach in the Imatinib Era
    Stiekema, Jurrien
    Kol, Sabrine
    Cats, Annemieke
    Yazdi, Amir T.
    van Coevorden, Frits
    van Sandick, Johanna W.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (05): : 502 - 507
  • [45] Some lessons learned from imatinib mesylate clinical development in gastrointestinal stromal tumors
    Casali, PG
    Bertulli, R
    Fumagalli, E
    Coco, P
    Grosso, F
    Stacchiotti, S
    JOURNAL OF CHEMOTHERAPY, 2004, 16 : 55 - 58
  • [46] Management of gastrointestinal stromal tumors: Looking beyond the knife. An update on the role of adjuvant and neoadjuvant imatinib therapy
    Richa Pandey
    Rajan Kochar
    Journal of Gastrointestinal Cancer, 2012, 43 (4) : 547 - 552
  • [47] Neoadjuvant Imatinib in Gastrointestinal Stromal Tumors (GIST): The First Analysis of a Mexican Population
    Guzman, Rafael Medrano
    Lara, Xavier Lopez
    Rivera, Atl Simon Arias
    Rios, Luis. E. Garcia
    Chaoul, Moises Brener
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [48] Characterizing gastrointestinal stromal tumors and evaluating neoadjuvant imatinib by sequencing of endoscopic ultrasound-biopsies
    Hedenstrom, Per
    Nilsson, Bengt
    Demir, Akif
    Andersson, Carola
    Enlund, Fredrik
    Nilsson, Ola
    Sadik, Riadh
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (32) : 5925 - 5935
  • [49] Metastatic gastrointestinal stromal tumor with long-term response after treatment with concomitant radiotherapy and imatinib mesylate
    Boruban, Cem
    Sencan, Orhan
    Akmansu, Muge
    Atik, Evrim Tunc
    Ozbek, Seda
    ANTI-CANCER DRUGS, 2007, 18 (08) : 969 - 972
  • [50] The effect of neoadjuvant Imatinib therapy on outcome and survival after rectal gastrointestinal stromal tumour
    Machlenkin, S.
    Pinsk, I.
    Tulchinsky, H.
    Ziv, Y.
    Sayfan, J.
    Duek, D.
    Rabau, M.
    Walfisch, S.
    COLORECTAL DISEASE, 2011, 13 (10) : 1110 - 1115